Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01195129 · ClinicalTrials.gov registry record · Phase 4
HydroCoil Cerebral Aneurysm Treatment Trial
A Phase 4 study, sponsored by University of Virginia.
- Terminated
- Registry status
- Phase 4
- Development phase
- 215
- Enrollment target
NCT01195129: Clinical Trial Phase 4 study, sponsored by University of Virginia.
NCT01195129 is a Phase 4 study that was terminated before completion, run by University of Virginia. The registered enrollment target is 215 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01195129, a Phase 4 study, was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 215 participants
- Enrollment target
Study Summary
The study will compare clinical and angiographic outcomes in patients receiving Hydrocoil aneurysm treatment versus patients receiving non-HydroCoil aneurysm treatment.
Primary Outcome
Angiographic occlusion, improvement or no change in the post-coiling appearance of the aneurysm as judged by an independent core lab on follow-up angiography at 12-18 months after endovascular treatment.
Interventions
- DEVICE MicroVention Hydrogel coil
- DEVICE Non-hydrogel coils
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2008-12 |
| Est. Completion | 2015-06 |
| Phase | Phase 4 |
Why NCT01195129 stopped before completion
NCT01195129 is an interventional study that assigns participants to a tested intervention. The registered 215 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 2 interventions - of which MicroVention Hydrogel coil is the first listed.
NCT01195129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01195129 about?
NCT01195129 is a clinical study titled "HydroCoil Cerebral Aneurysm Treatment Trial". The study will compare clinical and angiographic outcomes in patients receiving Hydrocoil aneurysm treatment versus patients receiving non-HydroCoil aneurysm treatment.
What is the current status of trial NCT01195129?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 215 participants. The study started on 2008-12. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01195129?
The interventions under investigation include: MicroVention Hydrogel coil (DEVICE), Non-hydrogel coils (DEVICE).
Who is sponsoring clinical trial NCT01195129?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01195129's enrollment target sits among peer trials
215 394th of 2000 higher than 1,607 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05134012 · 215 participants · Phase 3
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
- NCT05169970 · 215 participants · Phase 2
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
- NCT05197270 · 215 participants · Phase 1
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- NCT05230199 · 215 participants · NA
Sensory Optimization of the Hospital Environment
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia